Cargando…
Benefits and Hurdles of Pancreatic β-Cell Replacement
Insulin represents a life-saving treatment in patients with type 1 diabetes, and technological advancements have improved glucose control in an increasing number of patients. Despite this, adequate control is often still difficult to achieve and insulin remains a therapy and not a cure for the disea...
Autores principales: | Bolla, Andrea Mario, Montefusco, Laura, Pastore, Ida, Lunati, Maria Elena, Ben Nasr, Moufida, Fiorina, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585952/ https://www.ncbi.nlm.nih.gov/pubmed/36073717 http://dx.doi.org/10.1093/stcltm/szac058 |
Ejemplares similares
-
The Impact of Diabetes Mellitus on Cardiovascular Risk Onset in Children and Adolescents
por: Pastore, Ida, et al.
Publicado: (2020) -
One year of Hybrid Closed Loop on peritoneal dialysis: a case report
por: Rossi, Antonio, et al.
Publicado: (2022) -
Hybrid Close-Loop Systems Versus Predictive Low-Glucose Suspend and Sensor-Augmented Pump Therapy in Patients With Type 1 Diabetes: A Single-Center Cohort Study
por: Lunati, Maria Elena, et al.
Publicado: (2022) -
Abnormalities of the oculomotor function in type 1 diabetes and diabetic neuropathy
por: D’Addio, Francesca, et al.
Publicado: (2022) -
Hematopoietic Stem Cells in Type 1 Diabetes
por: Pastore, Ida, et al.
Publicado: (2021)